By enabling rapid, user-friendly, and reproducible analyses, AI-HOPE-TP53 provides a foundation for ongoing development toward clinically relevant and translational applications, while currently serving as a robust exploratory resource for the cancer research community. This evidence concerns the gene TP53 and cancer.